Hagen Thomas B 4
Research Summary
AI-generated summary
Erie Indemnity (ERIE) Director Thomas B. Hagen Acquires 39.474 Shares
What Happened
- Thomas B. Hagen, a director of Erie Indemnity Company, recorded an acquisition of 39.474 shares (derivative) on January 31, 2026. The transaction value is $11,172 based on a per-share amount of $283.01. The Form 4 was filed on February 2, 2026.
- This was not an open-market buy but an acquisition under the company’s directors’ deferred compensation/stock plan (share credits), i.e., a non-cash crediting of shares as part of director compensation.
Key Details
- Transaction date and price: 2026-01-31; 39.474 shares credited at $283.01 per share (total ~$11,172).
- Transaction type: Reported as “Other acquisition or disposition (J)” and marked as a derivative acquisition under the Directors’ Deferred Compensation Plan (footnote F4/F5).
- Shares owned after transaction: The total holdings after this single credit are not specified in the provided excerpt of the filing.
- Notable footnotes:
- F4/F5: These are share credits under the Outside Directors’/Directors’ Deferred Compensation Plan; share credits represent rights to receive Class A shares when the director’s service ends and have no exercise/expiration dates.
- F1/F2: The filing includes disclosures about certain shares tied to the late Susan Hirt Hagen’s trust and a family limited partnership; Mr. Hagen disclaims beneficial ownership of some reported securities except to the extent of his pecuniary interest.
- F3/F6: Additional technical notes on conversion/exercise not applicable to these deferred-share credits.
- Filing timing: Filed Feb 2, 2026 (two days after the reported Jan 31 transaction) as shown on the accession — appears to be a prompt Form 4 filing.
Context
- These are compensation-related share credits (derivative rights), not an open-market purchase or sale; such credits reflect pay/deferral elections and are not a direct signal of immediate buying or selling intentions.
- For retail investors, compensation credits are routine for directors and differ from outright purchases that might be interpreted as a stronger bullish signal.